Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
Conditions:   Colorectal Cancer;   Lynch Syndrome Intervention:   Drug: Omega-3 fatty acid ethyl esters (2 gram) Sponsor:   University of Kansas Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials